Editas Medicine (EDIT) Operating Expenses (2015 - 2025)

Editas Medicine (EDIT) has 11 years of Operating Expenses data on file, last reported at $32.1 million in Q3 2025.

• Quarterly Operating Expenses fell 51.18% year-over-year to $32.1 million in Q3 2025, while the trailing twelve-month figure through Dec 2025 was $168.0 million (down 40.72% YoY) and the FY2024 annual result came in at $283.5 million, up 14.62% from the prior year.
• Operating Expenses slipped to $32.1 million in Q3 2025 per EDIT's latest filing, from $55.1 million in the prior quarter.
• Across five years, Operating Expenses topped out at $84.0 million in Q4 2023 and bottomed at $32.1 million in Q3 2025.
• The 5-year median for Operating Expenses is $60.6 million (2022), against an average of $61.2 million.
• The widest annual swing landed in 2024, when Operating Expenses surged 54.14%; it then tumbled 51.18% in 2025.
• Tracing EDIT's Operating Expenses over 5 years: stood at $54.1 million in 2021, then climbed by 29.41% to $70.0 million in 2022, then climbed by 20.05% to $84.0 million in 2023, then declined by 8.11% to $77.2 million in 2024, then sank by 58.43% to $32.1 million in 2025.
• Per Business Quant, the three latest EDIT Operating Expenses figures stand at $32.1 million (Q3 2025), $55.1 million (Q2 2025), and $80.8 million (Q1 2025).

Peer Comparison